Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6814 stock hub

TPEX/6814 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6814is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6814

In the news

Latest news · TPEX/6814

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-30.3

P25 -16.2P50 0.3P75 9.8

ROIC-12.1

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6814 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

178

Groups with data

Currency

TWD

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	96
Employees Change	8%
Employees Change Percent	9.09
Enterprise value	TWD 1.2B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0006814007
Last refreshed	2026-05-10
Market cap	TWD 1.1B
Price	TWD 25.35
Price currency	TWD
Rev Per Employee	1,869,718.75x
Sector	Healthcare
Sic	2836
Symbol	tpex/6814
Website	https://www.lukas-biomedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.07%
EV Earnings	-13.81x
EV/FCF	-16.98x
EV/Sales	6.59x
FCF yield	-6.56%
P/B ratio	4.42x
P/S ratio	5.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-45.22%
EBITDA Margin	-31.27%
Gross margin	60.1%
Gross Profit	TWD 107.9M
Gross Profit Growth	-5.84%
Gross Profit Growth Q	-11.33%
Gross Profit Growth3 Y	-7.34%
Gross Profit Growth5 Y	1.7%
Net Income	TWD -85.6M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-46.67%
Profit Margin	-47.71%
Profit Per Employee	TWD -892,010
ROA	-11.23
Roa5y	-6.03
ROCE	-26.01
ROE	-30.26
Roe5y	-16.75
ROIC	-12.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	5.63%
Cagr3y	-12.66%
Cagr5y	-13.03%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	-16.12x
Revenue Growth Q	-9.76x
Revenue Growth Years	0x
Revenue Growth3 Y	-8.03x
Revenue Growth5 Y	-0.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.4
Assets	TWD 426.8M
Cash	TWD 34.7M
Current Assets	TWD 105.5M
Current Liabilities	TWD 86.9M
Debt	TWD 156M
Debt Equity	TWD 0.65
Debt FCF	TWD -2.24
Equity	TWD 240.2M
Interest Coverage	-25.28
Liabilities	TWD 186.6M
Long Term Assets	TWD 321.3M
Long Term Liabilities	TWD 99.7M
Net Cash	TWD -121.3M
Net Cash By Market Cap	TWD -11.42
Net Debt Equity	TWD 0.5
Tangible Book Value	TWD 239.9M
Tangible Book Value Per Share	TWD 5.76
WACC	4.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.8
Inventory Turnover	1.95
Net Working Capital	TWD 30.6M
Quick ratio	0.4
Working Capital	TWD -22.5M
Working Capital Turnover	TWD 2.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	5.63%
200-day SMA	26.97
3Y total return	-33.39%
50-day SMA	25.91
50-day SMA vs 200-day SMA	50under200
5Y total return	-50.25%
All Time High	76
All Time High Change	-66.64%
All Time High Date	2021-03-10
All Time Low	16.6
All Time Low Change	52.71%
All Time Low Date	2025-04-09
ATR	1.6
Beta	0.12
Beta1y	-0.19
Beta2y	0.05
Ch YTD	-18.23
High	25.35
High52	32.5
High52 Date	2025-12-09
High52ch	-22%
Low	24.15
Low52	20
Low52 Date	2025-07-17
Low52ch	26.75%
Ma50ch	-2.17%
Price vs 200-day SMA	-6.01%
RSI	48.39
RSI Monthly	42.29
RSI Weekly	42.09
Sharpe ratio	0.04x
Sortino ratio	0.26
Total Return	-13%
Tr YTD	-18.23
Tr1m	1.81%
Tr1w	1.4%
Tr3m	-11.98%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -81.2M
Operating margin	-45.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,299,350%
Net Borrowing	-43,826,000
Shares Insiders	7.71%
Shares Institutions	2.87%
Shares Out	41,874,371
Shares Qo Q	-0.06%
Shares Yo Y	13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -69.6M
Average Volume	21,944.9x
Bv Per Share	5.76
CAPEX	TWD -8.2M
Ch1m	1.81
Ch1w	1.4
Ch1y	5.63
Ch3m	-11.98
Ch3y	-33.64
Ch5y	-50.49
Ch6m	-16.06
Change	0%
Change From Open	0
Close	25.35
Days Gap	0
Depreciation Amortization	12,030,000
Dollar Volume	633.8
Earnings Date	2026-05-11
EBIT	TWD -81.2M
EBITDA	TWD -56.1M
EPS	TWD -2.05
F Score	3
FCF	TWD -69.6M
FCF EV Yield	-5.89x
FCF Per Share	TWD -1.66
Financing CF	40,097,000
Fiscal Year End	December
Founded	2,002
Income Tax	TWD 1.9M
Investing CF	-8,638,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-06-30
Ma150	28.04
Ma150ch	-9.59%
Ma20	25.22
Ma20ch	0.52%
Net CF	-29,967,000
Next Earnings Date	2026-05-11
Open	25.35
Position In Range	100
Ppne	68,864,000
Price Date	2026-05-08
Ptbv Ratio	4.42
Relative Volume	0x
Revenue	179,493,000x
Tax By Revenue	1.04x
Tr6m	-16.06%
Volume	25

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6814 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6814 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6814?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.9%

Share of float held by funds and institutions

Insider ownership

+7.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+13.0%

Negative means the company is buying back shares.

Technical

TPEX/6814 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.4

Neutral momentum band

Price vs 200-day MA

-6.0%

50/200-day relationship not available

Beta (5Y)

0.12

Less volatile than the market

Sharpe ratio

0.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6814

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6814 stock rating?

tpex/6814 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6814 analysis?

The full report lives at /stocks/tpex/6814/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6814?

The latest report frames tpex/6814 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6814 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.